Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from OneSource Specialty Pharma Limited ( (IN:ONESOURCE) ) is now available.
OneSource Specialty Pharma Limited has released its earnings presentation for the second quarter of the fiscal year 2026. The announcement, made after a board meeting, highlights the company’s financial performance and strategic direction, which may influence its market positioning and stakeholder interests.
More about OneSource Specialty Pharma Limited
OneSource Specialty Pharma Limited, formerly known as Stelis Biopharma Limited, operates in the pharmaceutical industry, focusing on specialty pharmaceuticals. The company is involved in the development and manufacturing of pharmaceutical products, catering to various market needs.
Average Trading Volume: 4,046
Technical Sentiment Signal: Strong Sell
Current Market Cap: 203.3B INR
For detailed information about ONESOURCE stock, go to TipRanks’ Stock Analysis page.